Literature DB >> 30787995

Protective effects of resveratrol on random-pattern skin flap survival: an experimental study.

Jinti Lin1,2,3, Renjin Lin1,2,3, Shihen Li1,2,3, Hongqiang Wu1,2,3, Jian Ding1,2,3, Guangheng Xiang1,2,3, Shi Li1,2,3, Yiru Wang4, Dingsheng Lin1,2,3, Weiyang Gao1,2,3, Jianzhong Kong1,2,3, Huazi Xu1,2,3, Kailiang Zhou1,2,3.   

Abstract

Random-pattern skin flap transplantation is a common procedure in plastic surgery, but its distal area usually incurs ischemia and necrosis. Resveratrol (Rev), a natural polyphenol primarily found in peanuts, grapes, and red wine, which exerts multi-bioactivity. In this study, forty-eight rats with the modified "McFarlane flap" model were divided into Control and Rev groups, which were treated with vehicle Control and Rev, respectively. After 7 days of continuous treatment and observation, ischemic flap tissues were harvested to evaluate angiogenesis, apoptosis, oxidative stress, and autophagy. It was observed a greater survival area of flaps, accompanied with reduced water content and stronger blood supply, in the Rev group than in the Control group. In addition, Rev upregulated the expression of MMP9, VEGF, and Cadherin5, indicating that Rev promotes angiogenesis in ischemic flaps. Moreover, Rev decreased the levels of Bax, CYC, and Caspase3, suggesting that it inhibits apoptosis. Besides, Rev increased the expression of SOD1, eNOS, HO1, the activities of SOD and GSH, and reduced the levels of MDA, which uncovers that it depresses oxidative stress in ischemic flaps. Finally, it increased the expression of Beclin1, LC3II, VPS34, and CTSD, and decreased SQSTM1/p62 levels, which reveals that it activates autophagy in the flaps. These results suggest that Rev promotes random skin flap survival through proangiogenic, antiapoptotic, and antioxidative effects; moreover, autophagy is activated in the process, which might be another underlying mechanism for the flap survival.

Entities:  

Keywords:  Resveratrol; angiogenesis; apoptosis; autophagy; oxidative stress; random-pattern skin flap

Year:  2019        PMID: 30787995      PMCID: PMC6357324     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  7 in total

1.  Curcumin promotes the survival of ischemic random skin flaps via autophagy.

Authors:  Zhuolong Tu; Xiaoqi Jiang; Yuan Li; Shiwei Yang; Deyong Lin; Yingfeng Shi; Cong Mao; Xingxing Zhang; Cai Lin
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Local skin flap procedure for repair of rectovaginal fistula: A case report.

Authors:  Kazunosuke Yamada; Taro Hirose; Hitoshi Ojima
Journal:  Int J Surg Case Rep       Date:  2022-09-19

3.  Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis.

Authors:  Xiaozhong Huang; Jia Sun; Gen Chen; Chao Niu; Ying Wang; Congcong Zhao; Jian Sun; Huiya Huang; Shuai Huang; Yangzhi Liang; Yingjie Shen; Weitao Cong; Litai Jin; Zhongxin Zhu
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

4.  Butylphthalide Inhibits Autophagy and Promotes Multiterritory Perforator Flap Survival.

Authors:  Baolong Li; Zhengtai Chen; Xiaobin Luo; Chenxi Zhang; Hongyu Chen; Shuxuan Wang; Mengyao Zhao; Haiwei Ma; Junling Liu; Mengshi Cheng; Yanyan Yang; Hede Yan
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

5.  Resveratrol Targets AKT1 to Inhibit Inflammasome Activation in Cardiomyocytes Under Acute Sympathetic Stress.

Authors:  Rui Wang; Yanming Wang; Jimin Wu; Yanli Guo; Han Xiao; Youyi Zhang; Ketao Ma
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

6.  Beclin-1/LC3-II dependent macroautophagy was uninfluenced in ischemia-challenged vascular endothelial cells.

Authors:  Yaping Ma; Chaofan Li; Yan He; Tiwei Fu; Li Song; Qingsong Ye; Fugui Zhang
Journal:  Genes Dis       Date:  2021-03-01

Review 7.  Tissue-Protective Mechanisms of Bioactive Phytochemicals in Flap Surgery.

Authors:  Andrea Weinzierl; Emmanuel Ampofo; Michael D Menger; Matthias W Laschke
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.